Skip to content
PubMed This is a summary of 46 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 46 referenced papers

Top Authors

Sergio D. Rosenzweig
National Institutes of Health
Julie E. Niemela
National Institutes of Health
Jennifer L. Stoddard
National Institutes of Health
Andrew Richard Gennery
Great North Children's Hospital
Tomohiro Morio
Tokyo Medical and Dental University
Motoi Yamashita
Tokyo Medical and Dental University
Giorgio Costagliola
Azienda Ospedaliera Universitaria Pisana
Rita Consolini
University of Pisa
Gabriella Casazza
Azienda Ospedaliera Universitaria Pisana
Luigi Daniele Notarangelo
National Institutes of Health

Top Institutions

Ranked by publications Top 10 institutions
03

Great North Children's Hospital

Newcastle upon Tyne, United Kingdom

45 papers
06

References

References (46)
  1. 1

    ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients.

    Maertens J, Cesaro S, Maschmeyer G, et al.

    The Journal of antimicrobial chemotherapy 2016; (71(9)):2397-404 doi:10.1093/jac/dkw157.

    PMID: 27550992
  2. 2

    A prospective study on the natural history of patients with profound combined immunodeficiency: An interim analysis.

    Speckmann C, Doerken S, Aiuti A, et al.

    The Journal of allergy and clinical immunology 2017; (139(4)):1302-1310.e4 doi:10.1016/j.jaci.2016.07.040.

    PMID: 27658761
  3. 3

    Vaccination in Primary Immunodeficiency Disorders.

    Sobh A, Bonilla FA

    The journal of allergy and clinical immunology. In practice 2016; (4(6)):1066-1075 doi:10.1016/j.jaip.2016.09.012.

    PMID: 27836056
  4. 4

    MHC-II Deficiency Among Egyptians: Novel Mutations and Unique Phenotypes.

    El Hawary RE, Mauracher AA, Meshaal SS, et al.

    The journal of allergy and clinical immunology. In practice 2019; (7(3)):856-863 doi:10.1016/j.jaip.2018.07.046.

    PMID: 30170160
  5. 5

    An Infant with Respiratory Distress and Loose Stools.

    Reddy P, Laishram D, Jindal AK, et al.

    Indian pediatrics 2018; (55(8)):693-697.

    PMID: 30218520
  6. 6

    Pneumocystis jirovecii pneumonia as an initial manifestation of hyper-IgM syndrome in an infant: A case report.

    Kim D, Shin JA, Han SB, et al.

    Medicine 2019; (98(7)):e14559 doi:10.1097/MD.0000000000014559.

    PMID: 30762803
  7. 7

    Clinical, Immunological, and Molecular Findings in 57 Patients With Severe Combined Immunodeficiency (SCID) From India.

    Aluri J, Desai M, Gupta M, et al.

    Frontiers in immunology 2019; (10()):23 doi:10.3389/fimmu.2019.00023.

    PMID: 30778343
  8. 8

    A Large Cohort of RAG1/2-Deficient SCID Patients-Clinical, Immunological, and Prognostic Analysis.

    Greenberg-Kushnir N, Lee YN, Simon AJ, et al.

    Journal of clinical immunology 2020; (40(1)):211-222 doi:10.1007/s10875-019-00717-1.

    PMID: 31838659
  9. 9

    Hematopoietic Stem Cell Transplantation for Combined Immunodeficiencies, on Behalf of IEWP-EBMT.

    Neven B, Ferrua F

    Frontiers in pediatrics 2019; (7()):552 doi:10.3389/fped.2019.00552.

    PMID: 32039114
  10. 10

    Interstitial pneumonia as the initial presentation in an infant with a novel mutation of CD40 ligand-associated X-linked hyper-IgM syndrome: A case report.

    Li J, Miao H, Wu L, Fang Y

    Medicine 2020; (99(24)):e20505 doi:10.1097/MD.0000000000020505.

    PMID: 32541472
  11. 11

    The challenges presented by haematopoietic stem cell transplantation in children with primary immunodeficiency.

    Gennery AR

    British medical bulletin 2020; (135(1)):4-15 doi:10.1093/bmb/ldaa017.

    PMID: 32676650
  12. 12

    Immune cytopenias as a continuum in inborn errors of immunity: An in-depth clinical and immunological exploration.

    Zama D, Conti F, Moratti M, et al.

    Immunity, inflammation and disease 2021; (9(2)):583-594 doi:10.1002/iid3.420.

    PMID: 33838017
  13. 13

    Recommendations for uniform definitions used in newborn screening for severe combined immunodeficiency.

    Blom M, Zetterström RH, Stray-Pedersen A, et al.

    The Journal of allergy and clinical immunology 2022; (149(4)):1428-1436 doi:10.1016/j.jaci.2021.08.026.

    PMID: 34537207
  14. 14

    T and B cell abnormalities, pneumocystis pneumonia, and chronic lymphocytic leukemia associated with an AIOLOS defect in patients.

    Kuehn HS, Chang J, Yamashita M, et al.

    The Journal of experimental medicine 2021; (218(12)) doi:10.1084/jem.20211118.

    PMID: 34694366
  15. 15

    AIOLOS Variants Causing Immunodeficiency in Human and Mice.

    Yamashita M, Morio T

    Frontiers in immunology 2022; (13()):866582 doi:10.3389/fimmu.2022.866582.

    PMID: 35444653
  16. 16

    Cernunnos defect in an Iranian patient with T- B+ NK+ severe combined immunodeficiency: A case report and review of the literature.

    Jamee M, Khakbazan Fard N, Fallah S, et al.

    Molecular genetics & genomic medicine 2022; (10(8)):e1990 doi:10.1002/mgg3.1990.

    PMID: 35656589
  17. 17

    Peripheral-blood cytopenia, an early indicator of inborn errors of immunity.

    Cornelissen HM, Musekwa EM, Glashoff RH, et al.

    British journal of haematology 2022; (198(5)):875-886 doi:10.1111/bjh.18337.

    PMID: 35791731
  18. 18

    A clinician's guide for administration of high-concentration and facilitated subcutaneous immunoglobulin replacement therapy in patients with primary immunodeficiency diseases.

    Epland K, Suez D, Paris K

    Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2022; (18(1)):87 doi:10.1186/s13223-022-00726-7.

    PMID: 36180928
  19. 19

    Pneumocystis jiroveci Pneumonia: A Review of Management in Human Immunodeficiency Virus (HIV) and Non-HIV Immunocompromised Patients.

    Ibrahim A, Chattaraj A, Iqbal Q, et al.

    Avicenna journal of medicine 2023; (13(1)):23-34 doi:10.1055/s-0043-1764375.

    PMID: 36969352
  20. 20

    Uncertainties experienced by parents of children diagnosed with severe combined immunodeficiency through newborn screening.

    Raspa M, Kutsa O, Andrews SM, et al.

    European journal of human genetics : EJHG 2024; (32(4)):392-398 doi:10.1038/s41431-023-01345-5.

    PMID: 36973394
  21. 21

    Positive Newborn Screening for Severe Combined Immunodeficiency: What Should the Pediatrician Do?

    Mongkonsritragoon W, Huang J, Fredrickson M, et al.

    Clinical medicine insights. Pediatrics 2023; (17()):11795565231162839 doi:10.1177/11795565231162839.

    PMID: 37025258
  22. 22

    Low-Dose TMP-SMX for Pneumocystis jirovecii Pneumonia Prophylaxis in Pediatric Solid Organ Transplant Recipients.

    Chen JK, Guerci J, Corbo H, et al.

    The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG 2023; (28(2)):123-128 doi:10.5863/1551-6776-28.2.123.

    PMID: 37139252
  23. 23

    A personalized approach to lymphoproliferations in patients with inborn errors of immunity.

    Naor S, Adam E, Schiby G, Gratzinger D

    Seminars in diagnostic pathology 2023; (40(6)):408-419 doi:10.1053/j.semdp.2023.07.001.

    PMID: 37479638
  24. 24

    Disease-associated AIOLOS variants lead to immune deficiency/dysregulation by haploinsufficiency and redefine AIOLOS functional domains.

    Kuehn HS, Sakovich IS, Niemela JE, et al.

    The Journal of clinical investigation 2024; (134(3)).

    PMID: 38015619
  25. 25

    The transcription factor Aiolos restrains the activation of intestinal intraepithelial lymphocytes.

    Yomogida K, Trsan T, Sudan R, et al.

    Nature immunology 2024; (25(1)):77-87 doi:10.1038/s41590-023-01693-w.

    PMID: 38049581
  26. 26

    Population pharmacokinetics of immunoglobulin G after intravenous, subcutaneous, or hyaluronidase-facilitated subcutaneous administration in immunoglobulin-naive patients with primary immunodeficiencies.

    Li Z, Follman K, Freshwater E, et al.

    International immunopharmacology 2024; (128()):111447 doi:10.1016/j.intimp.2023.111447.

    PMID: 38185032
  27. 27

    Immunoglobulin replacement therapies in inborn errors of immunity: a review.

    Sil A, Basu S, Joshi V, et al.

    Frontiers in pediatrics 2024; (12()):1368755 doi:10.3389/fped.2024.1368755.

    PMID: 38425666
  28. 28

    Parental Engagement in Identifying Information Needs After Newborn Screening for Families of Infants with Suspected Athymia.

    Howley E, Soomann M, Kreins AY

    Journal of clinical immunology 2024; (44(3)):79 doi:10.1007/s10875-024-01678-w.

    PMID: 38457046
  29. 29

    Evaluation of effectiveness, hyperkalaemia, and hepatotoxicity of trimethoprim-sulphamethoxazole prophylaxis for Pneumocystis jirovecii pneumonia in paediatric patients: A single-centre retrospective study.

    Kato H, Hagihara M, Asai N, et al.

    International journal of antimicrobial agents 2024; (63(5)):107151 doi:10.1016/j.ijantimicag.2024.107151.

    PMID: 38508538
  30. 30

    Identification and Functional Analysis of a de novo IKZF3 Mutation in a Pediatric Patient with Combined Immunodeficiency.

    Shi X, Cao X, Huang M, et al.

    Journal of clinical immunology 2024; (44(5)):117 doi:10.1007/s10875-024-01706-9.

    PMID: 38758229
  31. 31

    The Etiologic Landscape of Lymphoproliferation in Childhood: Proposal for a Diagnostic Approach Exploring from Infections to Inborn Errors of Immunity and Metabolic Diseases.

    Costagliola G, De Marco E, Massei F, et al.

    Therapeutics and clinical risk management 2024; (20()):261-274 doi:10.2147/TCRM.S462996.

    PMID: 38770035
  32. 32

    AIOLOS-Associated Inborn Errors of Immunity.

    Yamashita M, Morio T

    Journal of clinical immunology 2024; (44(6)):128 doi:10.1007/s10875-024-01730-9.

    PMID: 38773004
  33. 33

    Transcriptional function of E2A, Ebf1, Pax5, Ikaros and Aiolos analyzed by in vivo acute protein degradation in early B cell development.

    Fedl AS, Tagoh H, Gruenbacher S, et al.

    Nature immunology 2024; (25(9)):1663-1677 doi:10.1038/s41590-024-01933-7.

    PMID: 39179932
  34. 34

    Hematopoietic stem cell transplantation for primary immunodeficiency.

    Alsaati N, Grier A, Ochfeld E, et al.

    Allergy and asthma proceedings 2024; (45(5)):371-383 doi:10.2500/aap.2024.45.240069.

    PMID: 39294909
  35. 35

    Immunodeficiency: Burden of Illness.

    Hsueh JC, Van Hersh AT, Zhao W

    Allergy and asthma proceedings 2024; (45(5)):294-298 doi:10.2500/aap.2024.45.240060.

    PMID: 39294910
  36. 36

    Immunoglobulin therapy for immunodeficiency.

    Wilson BE, Freeman CM

    Allergy and asthma proceedings 2024; (45(5)):364-370 doi:10.2500/aap.2024.45.240053.

    PMID: 39294913
  37. 37

    Effectiveness, Safety, and Treatment Satisfaction of 20% Subcutaneous Immunoglobulin Replacement Therapy in Pediatric Patients with Primary and Secondary Immunodeficiencies.

    Sefer AP, Kaya MS

    Turkish archives of pediatrics 2025; (60(2)):217-225 doi:10.5152/TurkArchPediatr.2025.24305.

    PMID: 40094369
  38. 38

    Inborn errors of immunity presenting with lymphoproliferation: lessons from a case series.

    Costagliola G, De Marco E, Consonni F, et al.

    Annals of hematology 2025; (104(6)):3117-3127 doi:10.1007/s00277-025-06456-1.

    PMID: 40553169
  39. 39

    Inborn Errors of Immunity in Pediatric Hematology and Oncology: Diagnostic Principles for Clinical Practice.

    Roberti G, Maestrini G, Polito B, et al.

    Journal of clinical medicine 2025; (14(17)) doi:10.3390/jcm14176295.

    PMID: 40944054
  40. 40

    Current infectious disease management challenges in inborn errors of immunity.

    Zheng S, Lowe DM

    Annals of clinical microbiology and antimicrobials 2025; (24(1)):60 doi:10.1186/s12941-025-00830-7.

    PMID: 41163029
  41. 41

    X-linked severe combined immunodeficiency due to IL2RG p.V223F variant: clinical evidence that support its pathogenicity- a case report.

    Gutiérrez-Zepeda BM, Lona-Reyes JC, Cruz-Muñoz ME, et al.

    Frontiers in immunology 2026; (17()):1776191 doi:10.3389/fimmu.2026.1776191.

    PMID: 42058195
  42. 42

    [Immunoglobulin Replacement Therapy in Antibody Production Defects].

    Bernardino A, Abdurrachid N, Varandas C, et al.

    Acta medica portuguesa 2026; (39(5)):366-371 doi:10.20344/amp.24119.

    PMID: 42104827
  43. 43

    Practice parameter for inborn errors of immunity: What is new in the 2025 update.

    Chinen J, Horner CC, Orange JS

    The Journal of allergy and clinical immunology 2026; (158(2)):368-373 doi:10.1016/j.jaci.2026.05.014.

    PMID: 42208906
  44. 44

    Shared Decision-Making and Health-Related Quality of Life in the Diagnosis and Management of Patients With Inborn Errors of Immunity.

    Lawrence MG, Kim VHD, Orange JS, Scherzer R

    The journal of allergy and clinical immunology. In practice 2026; doi:10.1016/j.jaip.2026.07.010.

    PMID: 42447994
  45. 45

    Multidisciplinary Delphi consensus on malignancy screening in patients with common variable immunodeficiency.

    Cabanero-Navalon MD, de Andrés-Martín A, Gil AA, et al.

    Frontiers in immunology 2026; (17()):1897051 doi:10.3389/fimmu.2026.1897051.

    PMID: 42676356
  46. 46

    Pre-diagnosis emotions and experiences of parents of children with immunodeficiency disorders: A qualitative study.

    Coşkun Şimşek D, Polat F, Bahçecioğlu Turan G, Kiliç M

    Journal of pediatric nursing 2026; doi:10.1016/j.pedn.2026.09.029.

    PMID: 42791134